Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
11,232.00 GBX | -0.74% |
|
-5.18% | +7.30% |
03-26 | Lunit to Present AI Study on EGFR Mutation Prediction in NSCLC at AACR 2025 in Collaboration with AstraZeneca | CI |
03-26 | ASTRAZENECA : JP Morgan reaffirms its Buy rating | ZD |
Evolution of the Average Target: AstraZeneca PLC
Evolution of the Target Price: AstraZeneca PLC
Changes in Analyst Recommendations: AstraZeneca PLC
Consensus | 4m Revision of opinion | Divergence of analysts' opinions | Divergence of Target Price | Ecart obj. / dr | ||
---|---|---|---|---|---|---|
+23.1% | ||||||
+18.55% | ||||||
+5% | ||||||
+5.16% | ||||||
+56.89% | ||||||
+3.05% | ||||||
+27.54% | ||||||
+2.28% | ||||||
+2.96% | ||||||
+22.34% | ||||||
Average | +16.69% | |||||
Weighted average by Cap. | +17.22% |
Analysts' Consensus

Analyst Consensus Detail
Consensus revision (last 18 months)
Analysts covering the company
BERNSTEIN RESEARCH | Justin Smith |
GOLDMAN SACHS | Rajan Sharma |
UBS | Matthew Weston |
JPMORGAN | James Gordon |
AlphaValue/Baader Europe | |
BERENBERG | Luisa Hector |
Morgan Stanley | |
DEUTSCHE BANK RESEARCH | Emmanuel Papadakis |
DZ BANK | Elmar Kraus |
alphavalue | Abhishek Raval |
JEFFERIES | Peter Welford |
Carnegie Group | |
Berenberg Bank | |
Intron Health | |
Deutsche Bank Securities | |
Nordea Bank | |
BARCLAYS | Emily Field |
HSBC | |
Stifel Nicolaus | |
Jefferies & Co. | |
Bernstein | |
RBC Capital Markets | |
B. Riley | |
BMO Capital | |
CREDIT SUISSE | Dominic Lunn |
Argus | |
Bank of America Securities/Merrill Lynch | |
Danske Bank Group | |
Kepler Capital Markets | |
Kepler Cheuvreux | |
DEUTSCHE BANK | Emmanuel Papadakis |
SVB Leerink | |
Bryan, Garnier & Co. | |
Societe Generale | |
Liberum Capital | |
ODDO BHF | |
BANK OF AMERICA (BOFA) | Sachin Jain |
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- AZN Stock
- Consensus AstraZeneca PLC

MarketScreener is also available in this country: United States.
Switch edition